Synthesis and Characterization of a Novel γ-Aminobutyric Acid Type A (GABAA) Receptor Ligand That Combines Outstanding Metabolic Stability, Pharmacokinetics, and Anxiolytic Efficacy.
J Med Chem
; 59(23): 10800-10806, 2016 12 08.
Article
em En
| MEDLINE
| ID: mdl-27933953
ABSTRACT
1,4-Benzodiazepines are used in the treatment of anxiety disorders but have limited long-term use due to adverse effects. HZ-166 (2) has been shown to have anxiolytic-like effects with reduced sedative/ataxic liabilities. A 1,3-oxazole KRM-II-81 (9) was discovered from a series of six bioisosteres with significantly improved pharmacokinetic and pharmacodynamic properties as compared to 2. Oxazole 9 was further characterized and exhibited improved anxiolytic-like effects in a mouse marble burying assay and a rat Vogel conflict test.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Oxazóis
/
Ansiolíticos
/
Benzodiazepinas
/
Receptores de GABA-A
/
Antagonistas de Receptores de GABA-A
/
Imidazóis
Limite:
Animals
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article